KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Merck (MRK) Cash from Discontinued Operations (2020 - 2021)

Merck (MRK) has disclosed Cash from Discontinued Operations for 2 consecutive years, with 702000000.0 as the latest value for Q4 2021.

Quarterly Cash from Discontinued Operations fell 217.79% to 702000000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 702000000.0 through Sep 2022, down 142.62% year-over-year, with the annual reading at 349000000.0 for FY2021, 86.76% down from the prior year.
Cash from Discontinued Operations for Q4 2021 was 702000000.0 at Merck, down from 552000000.0 in the prior quarter.
The five-year high for Cash from Discontinued Operations was 691000000.0 in Q3 2020, with the low at 702000000.0 in Q4 2021.